Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 1
Submit an article Journal homepage
282
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors

Daphné Dupéré-RicherSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Mena KinalSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Filippa PetterssonSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Audrey EmondSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
M. Nieves Calvo-VidalDivision of Hematology and Oncology, Department of Medicine, Cornell University, New York, NY, USA;
,
Jessica N. NicholSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Cynthia GuilbertSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Dany PlourdeSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Kathleen Klein OrosSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Torsten H. NielsenSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Teresa EzpondaDivision of Hematology/Oncology, Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
,
Jonathan D. LichtDivision of Hematology/Oncology, Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
,
Nathalie A. JohnsonSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Sarit AssoulineSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada;
,
Leandro CerchiettiDivision of Hematology and Oncology, Department of Medicine, Cornell University, New York, NY, USA;
,
Wilson H. Miller Jr.Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada; Correspondence[email protected]; [email protected]
&
Koren K. MannSegal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montréal, QC, Canada; Correspondence[email protected]; [email protected]
 show all
Pages 218-221 | Received 18 Dec 2015, Accepted 13 Apr 2016, Published online: 17 May 2016

References

  • Crump M, Coiffier B, Jacobsen ED, et al. Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol. 2008;19:964–969.
  • O'Connor OA, Heaney ML, Schwartz L, et al. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies. J Clin Oncol. 2006;24:166–173.
  • Molife LR, Attard G, Fong PC, et al. Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC). Ann Oncol. 2010;21:109–113.
  • Ogura M, Ando K, Suzuki T, et al. A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Br J Haematol. 2014;165:768–776.
  • Haas NB, Quirt I, Hotte S, et al. Phase II trial of vorinostat in advanced melanoma. Invest New Drugs. 2014;32:526–534.
  • Lakshmaiah KC, Jacob LA, Aparna S, et al. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther. 2014;10:469–478.
  • Clozel T, Yang S, Elstrom RL, et al. Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer Discov. 2013;3:1002–1019.
  • Jiang Y, Hatzi K, Shaknovich R. Mechanisms of epigenetic deregulation in lymphoid neoplasms. Blood. 2013;121:4271–4279.
  • Dupere-Richer D, Kinal M, Menasche V, et al. Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance. Cell Death Dis. 2013;4:e486
  • Tsang KY, Chan D, Bateman JF, et al. In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J Cell Sci. 2010;123:2145–2154.
  • Olzmann JA, Kopito RR, Christianson JC. The mammalian endoplasmic reticulum-associated degradation system. Cold Spring Harb Perspect Biol. 2013;5:a013185.
  • Bhatt S, Ashlock BM, Toomey NL, et al. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. J Clin Invest. 2013;123:2616–2628.
  • Dasmahapatra G, Lembersky D, Kramer L, et al. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo. Blood. 2010;115:4478–4487.
  • Dasmahapatra G, Lembersky D, Son MP, et al. Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo. Mol Cancer Ther. 2011;10:1686–1697.
  • San-Miguel JF, Richardson PG, Gunther A, et al. Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma. J Clin Oncol. 2013;31:3696–3703.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.